Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
April 17, 2020
|
| |
| | | | | "I am proud of our ICU teams in how they've provided excellent clinical care to COVID-19 patients during these challenging times," says Dr. Sara Auld.
Sara Auld, MD, MSc, Assistant Professor, Emory University School of Medicine and Rollins School of Public Health, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) graduate, has helped her team develop best practices and guidelines for ... | | | | Read More | | |
|
| |
| | | | | | Georgia CTSA is taking an active role in monitoring the COVID-19 pandemic and sharing important news updates. We are continuously collecting and sharing news of how our trainees, scholars, investigators, faculty, and staff are responding to the COVID-19 virus. Review the Georgia CTSA COVID-19 Response webpage to learn more about how our researchers are responding in the battle against COVID-19 and for more information on resources available. | | | | Read More | | |
|
| |
| | | | Hear from the experts and share your experiences! Join Dr. Lawrence Boise, PhD, from Emory University and Dr. Steven Stice, PhD, from the University of Georgia for an online discussion about managing and supporting lab trainees during this uncertain time.
April 28 from 1:00 - 2:00 p.m.
| | | | Register | | |
| |
| | | | With information and funding opportunities quickly evolving during this pandemic, we want to make sure our NCATS Consortium has the most up-to-date and readily available information. You can find the latest opportunities that NCATS is participating in, by following this link below. | | | | Read More | | |
| |
| | | | For up-to-date NIH COVID-19 information, including: Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and; Funding Opportunities, please visit the link below. | | | | Read More | | |
| |
| | | | The COVID-19 global emergency raises many difficult questions, such as: who is infectious, who may need hospital care and at what level, what are the key risk factors, and more. To address these and many other questions, the National Center for Data to Health and NCATS are leading the creation of a national, centralized, secure portal for COVID-19 clinical data. The cloud-based collaborative portal will allow for the development of machine learning and other informatics tools that require a large row-level dataset and will be overseen by a data access committee. We believe this portal will provide additional assets needed to rapidly develop the analytics that clinical centers and physicians need now. | | | | Read More | | |
| |
| | | | This initiative will support multidisciplinary research examining mechanisms underlying racial and ethnic disparities in maternal mortality and morbidity, testing the efficacy and/or effectiveness of multi-level interventions, and/or research strategies to optimally and sustainably deliver proven-effective prevention and treatment interventions to reduce these disparities. Application budgets should reflect the actual needs of the proposed project and are limited to $500,000 per year in direct costs. The award project period is 5 years. | | | | Read More | | |
| |
| | | | A key innovation strategy is to promote interdisciplinary and cross-departmental and -divisional research. The SOM I3 Education Awards are soliciting proposals that highlight, promote, and disseminate innovations in medical education and training (degree programs and GME) that enhance the Emory SOM mission. Please note that the project start date is now listed as “TBD.” We will re-evaluate the start date when we review proposals and better understand where research stands across Emory at that time. | | | | Read More | | |
| |
| | | | The National Human Genome Research Institute (NHGRI) announces the availability of funds to support the development and implementation of modules aimed at providing health care professionals with genomic medicine training. Topics include clinical use of genomic data, genomic tests, analysis of clinical genomic data, pharmacogenomics, use of genomic information for preventive medicine, etc. Development of training materials and/or curriculum needs to be within the scope of the parent grant. Application budgets are limited to $125,000 total costs per year. | | | | Read More | | |
| |
| | | | Considering the disruptions caused by the COVID-19 global pandemic, there is a critical need to maintain an uninterrupted development and distribution of continuing education for healthcare providers, specifically as it relates to the care and treatment of patients that are considered immunocompromised. Through this RFP, it is our intent to support virtual programs for Healthcare Practitioners (HCPs) that treat Ulcerative Colitis. Programs that leverage virtual technologies to help HCPs meet the ever-changing needs of patients during this challenging time will be supported. | | | | Read More | | |
| |
| | | | Due to the disruption caused by the COVID-19 crisis, Emory SOM is postponing the deadline for Bridge Funding applications to May 15, 2020. In addition, we are adding two contingencies to this round: 1) The start date for Bridge awards will be dependent on the University research ramp-up timeline and 2) Bridge funding will be contingent on the SOM budget at the time of award. | | | | Read More | | |
| |
| | | | National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest to highlight the urgent need for research on the 2019 novel coronavirus and the disease it causes. NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. | | | | Read More | | |
| |
| | | | Pfizer Global Medical Grants support patient-focused programs that help patients and providers address the heightened medical and educational needs of patients with primary immunodeficiency during this pandemic. Priority will be awarded to projects that leverage the utilization of innovative technology platforms for distant learning to reach the intended audience with a focus on patient outreach, medical support and telework. | | | | Read More | | |
| |
| | | | AMAG Pharmaceuticals, Inc. is committed to funding research aimed at reducing the risk of premature birth and preeclampsia in order to improve the health of neonates and infants in the United States through its 2020 Prematurity and Preeclampsia Research Grants Program for a total of $250,000. Consideration will be given to basic or clinical research in maternal, fetal and neonatal/infant health. | | | | Read More | | |
| |
| | | | The purpose of this Notice of Special Interest is to highlight the list of widely appreciated systematic barriers or translational science problems included in PAR-19-099 and PAR-19-100 to add the following topics of interest: Rural Health, Racial and Ethnic Disparities in Maternal Mortality, Applications for Machine Learning and Artificial Intelligence (AI), Veterans' Health. | | | | Read More | | |
| |
| | | | The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently funded individual and/or collaborative research projects more efficiently and/or more effectively. Application budgets are limited to $500,000 direct costs per year. The maximum project period is 5 years. | | | | Read More | | |
| |
| | | | The Certificate Program in Translational Research (CPTR) is a formal 16-credit Emory Laney Graduate School program for trainees who seek to conduct research at the interface between basic and translational science and clinical medicine. | | | | Read More | | |
| |
| | | | The Medical Innovation Residency Track is a 24-month program now open to both Emory and MSM participants to provide a foundation of knowledge to participate in entrepreneurship and design for innovate technologies. Upon successful participation and completion of this track, residents will be awarded a certificate of distinction in Medical Innovation from Emory University School of Medicine. | | | | Read More | | |
| |
| | | | The Georgia Clinical & Translational Science Alliance TEAMS (Translational Education and Mentoring for Science) Program is seeking learning community mentors, one-on-one mentors and content experts to participate in the 2020-2021 academic year program. Submit Interest Form by June 1. https://www.surveymonkey.com/r/TSDDV92 | | | | Read More | | |
| |
| | | | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | | | Volunteer Form | | |
| |
| | | | Are you pursuing a NIH award (K, R, SC, U), Diversity Supplement, or Pilot Grant? Apply to participate in NRMN’s Research Study. The importance of the study is to examine the effects of Early Stage Investigators (ESIs) characteristics, contextual factors, as well as institutional contexts that shape their social capital, research productivity, and career persistence. | | | | Read More | | |
| |
| | | | Many Emory investigators are pursuing essential and critical research projects focused on the COVID-19 pandemic. If you have plans to collect or are currently collecting samples from COVID-19 patients, please respond with a brief description of your work and the type of sample (DNA, serum, PBMCs) you need. Providing essential platforms to support COVID-19 research is a high priority. Requests for new equipment to directly support COVID-19 research are being collected via email. Please send email to Mike Zwick at mzwick@emory.edu. | | | | Read More | | |
| |
| | | | CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new treatments for neglected diseases. CURE ID is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). | | | | Read More | | |
| |
| | | | We are a community of medical professionals, life scientists and data scientists on a quest to defeat COVID-19. To pitch in, join our discourse! | | | | Read More | | |
| |
| | | | The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world. Learn more about how to request access to resources of the COVID-19 HPC Consortium. | | | | Read More | | |
| |
| | | | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | | | Submit a Request | | |
| |
| | | | Allocating Credit: But That Was My Idea! (PDF) | | | | Read More | | |
| |
| | | | Georgia Tech CREATE-X, Coulter Dept. of Biomedical Engineering, and Emory Global Health Initiatives are partnering to host a virtual "hackathon" with students from both schools to pursue solutions to challenging problems sparked by the COVID-19 pandemic. This initiative will have teams of at least one GT and one Emory student per team to develop a solution to the problem. The winners will receive the opportunity to move the solution forward through CREATE-X Startup Launch Accelerator. We are interested to learn about problems currently being experienced, problems that may be due to a surge of patients, or broader problems the general public may face as we approach the tail of the pandemic. For this survey, identifying the problem is more important than proposing a solution. Questions? Contact: rahulsaxena@gatech.edu. | | | | Learn More | | |
| |
| | | | Registration is now open for the SBIR Road Tour stopping at UGA in Athens, GA. National outreach effort connecting entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the SBIR/STTR programs. Opportunity for small businesses, innovators, researchers, entrepreneurs and technology companies to connect directly with SBIR/STTR program managers representing more than a dozen different federal agencies. SBIR/STTR programs provide over $3.7 billion in funding to small businesses each year in a wide variety of technology areas. | | | | Read More & Register | | |
| |
| | | | EGHI invites interested writers and illustrators to write and illustrate a children-s eBook aimed at providing information on the COVID-19 pandemic. The eBook content should include age-appropriate, factual information, reassure the reader they are safe and that it is okay to feel upset, and describe actions taken by medical professionals and others. Other content could include behaviors to help them stay safe and healthy such as appropriate handwashing techniques, social distancing, healthy diets and rest. Winner will receive $10,000 plus online publication of their eBook on the EGHI website, social media platforms, and all EGHI promotional materials. | | | | Read More | | |
| |
| | | | Interested in administrative data sets (e.g., PHIS, claims)? Come learn strategies to prevent your projects from PHISzling out! Join us through Zoom from 12 pm- 1 pm. | | | | Read More | | |
| |
| | | | Join Emory Comprehensive Glycomics Core at 11:00 AM as Dr. Denes Agoston discusses Reverse Phase Protein Arrays (RPPA), which have been successfully used in various aspects of neurology research. RPPA is a robust, sensitive, and high throughput analytical platform that can be adapted to many other fields of biomedical research. This presentation will discuss the advantages and challenges of using RPPA technology. | | | | Read More | | |
| |
| | | | Join this free webinar from 2:00 - 3:00 p.m. to learn the pros and cons of different commercialization strategies to help determine the best fit for your technology. Our panel discussion format will allow you to ask questions and receive feedback to better understand complex go-to-market strategies. Please note all talks for the remainder of this series will be hosted via webinar. | | | | Register | | |
| |
| | | | Hear from the experts and share your experiences from 1:00 - 9:00 p.m.! Join Dr. Lawrence Boise, PhD, from Emory University and Dr. Steven Stice, PhD, from the University of Georgia for an online discussion about managing and supporting lab trainees during this uncertain time.
| | | | Register | | |
| |
| | | | Thank you for your commitment to pediatric research and interest in attending the Southeastern Pediatric Research Conference. We have been closely monitoring the COVID-19 outbreak, and in an effort to keep everyone safe and healthy, we have made the difficult decision to cancel this event. During the time you had reserved to participate in the conference, we strongly encourage you to participate instead in a special three-hour COVID-19 webinar highlighting several current COVID-19-related research projects. The specific time and complete agenda will be announced here as soon as they are available. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
